Detalles de la búsqueda
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38055253
2.
Characterization of mismatch-repair/microsatellite instability-discordant endometrial cancers.
Cancer
; 130(3): 385-399, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751191
3.
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Gynecol Oncol
; 182: 51-56, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262238
4.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593674
5.
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.
Gynecol Oncol
; 175: 32-40, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321153
6.
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Gynecol Oncol
; 177: 46-52, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37639902
7.
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
Gynecol Oncol
; 173: 15-21, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37037083
8.
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Gynecol Oncol
; 178: 14-22, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741201
9.
Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.
Gynecol Oncol
; 177: 38-45, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634258
10.
Safety and feasibility of same-day discharge following minimally invasive hysterectomy in the morbidly obese patient population.
Gynecol Oncol
; 170: 203-209, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709661
11.
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.
Gynecol Oncol
; 178: 44-53, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748270
12.
Postoperative venous thromboembolism risk stratification in patients with uterine cancer.
Am J Obstet Gynecol
; 228(5): 555.e1-555.e8, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36574873
13.
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer.
Am J Obstet Gynecol
; 228(1): 59.e1-59.e13, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35931127
14.
Characterization of Patients with Frequent Utilization of the Obstetric Triage Unit: A Retrospective Cohort Study.
Am J Perinatol
; 2023 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36894158
15.
Racial Disparities in Surgical Outcomes Among Women with Endometrial Cancer.
Ann Surg Oncol
; 29(13): 8338-8344, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36138286
16.
Hospital-based ovarian cancer patient traceback program results in minimal genetic testing uptake.
Gynecol Oncol
; 164(3): 615-621, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34998598
17.
Racial and ethnic disparities in readmission risk following the surgical management of endometrial cancer.
Gynecol Oncol
; 166(3): 543-551, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35882610
18.
The contemporary presentation and diagnosis of endometrial cancer recurrence: When, where, and how?
Gynecol Oncol
; 167(2): 174-180, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36154763
19.
Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: An implication for the antitumor potential of DAP compound.
Gynecol Oncol
; 164(1): 136-145, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34756749
20.
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 164(2): 398-405, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34857397